nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—asthma—chronic obstructive pulmonary disease	0.201	1	CtDrD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Prednisolone—chronic obstructive pulmonary disease	0.15	0.514	CiPCiCtD
Betamethasone—Corticosteroid Hormone Receptor Agonists—Prednisone—chronic obstructive pulmonary disease	0.141	0.486	CiPCiCtD
Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.104	0.506	CrCtD
Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.101	0.494	CrCtD
Betamethasone—NR3C2—Prednisolone—chronic obstructive pulmonary disease	0.0424	0.439	CbGbCtD
Betamethasone—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.014	0.145	CbGbCtD
Betamethasone—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0132	0.137	CbGbCtD
Betamethasone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00579	0.06	CbGbCtD
Betamethasone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00391	0.0405	CbGbCtD
Betamethasone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00373	0.0387	CbGbCtD
Betamethasone—Flurandrenolide—Prednisolone—chronic obstructive pulmonary disease	0.00367	0.0249	CrCrCtD
Betamethasone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00333	0.0345	CbGbCtD
Betamethasone—Prednicarbate—Prednisone—chronic obstructive pulmonary disease	0.0033	0.0224	CrCrCtD
Betamethasone—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.0033	0.0224	CrCrCtD
Betamethasone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00326	0.0338	CbGbCtD
Betamethasone—Beclomethasone—Prednisolone—chronic obstructive pulmonary disease	0.00323	0.0219	CrCrCtD
Betamethasone—Prednicarbate—Prednisolone—chronic obstructive pulmonary disease	0.00323	0.0219	CrCrCtD
Betamethasone—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.00323	0.0219	CrCrCtD
Betamethasone—Clocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00323	0.0219	CrCrCtD
Betamethasone—Fluocortolone—Prednisone—chronic obstructive pulmonary disease	0.00321	0.0218	CrCrCtD
Betamethasone—Fluocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00313	0.0213	CrCrCtD
Betamethasone—Alclometasone—Prednisone—chronic obstructive pulmonary disease	0.00312	0.0212	CrCrCtD
Betamethasone—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00308	0.0319	CbGbCtD
Betamethasone—Alclometasone—Prednisolone—chronic obstructive pulmonary disease	0.00305	0.0207	CrCrCtD
Betamethasone—Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.00305	0.0207	CrCrCtD
Betamethasone—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.00304	0.0206	CrCrCtD
Betamethasone—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.00304	0.0206	CrCrCtD
Betamethasone—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.00297	0.0201	CrCrCtD
Betamethasone—Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.00297	0.0201	CrCrCtD
Betamethasone—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.00297	0.0201	CrCrCtD
Betamethasone—Desonide—Prednisone—chronic obstructive pulmonary disease	0.00296	0.0201	CrCrCtD
Betamethasone—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00296	0.0201	CrCrCtD
Betamethasone—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00296	0.0201	CrCrCtD
Betamethasone—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.00296	0.0201	CrCrCtD
Betamethasone—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.00296	0.0201	CrCrCtD
Betamethasone—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.00289	0.0196	CrCrCtD
Betamethasone—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00289	0.0196	CrCrCtD
Betamethasone—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00289	0.0196	CrCrCtD
Betamethasone—Desonide—Prednisolone—chronic obstructive pulmonary disease	0.00289	0.0196	CrCrCtD
Betamethasone—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00289	0.0196	CrCrCtD
Betamethasone—Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.00289	0.0196	CrCrCtD
Betamethasone—Paramethasone—Prednisone—chronic obstructive pulmonary disease	0.00288	0.0196	CrCrCtD
Betamethasone—Paramethasone—Prednisolone—chronic obstructive pulmonary disease	0.00282	0.0191	CrCrCtD
Betamethasone—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00281	0.0191	CrCrCtD
Betamethasone—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.00275	0.0187	CrCrCtD
Betamethasone—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.00275	0.0187	CrCrCtD
Betamethasone—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.00275	0.0187	CrCrCtD
Betamethasone—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.00275	0.0187	CrCrCtD
Betamethasone—Mometasone—Prednisone—chronic obstructive pulmonary disease	0.00275	0.0187	CrCrCtD
Betamethasone—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00275	0.0187	CrCrCtD
Betamethasone—Rimexolone—Prednisone—chronic obstructive pulmonary disease	0.00269	0.0182	CrCrCtD
Betamethasone—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00269	0.0182	CrCrCtD
Betamethasone—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.00268	0.0182	CrCrCtD
Betamethasone—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.00268	0.0182	CrCrCtD
Betamethasone—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.00268	0.0182	CrCrCtD
Betamethasone—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.00268	0.0182	CrCrCtD
Betamethasone—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00268	0.0182	CrCrCtD
Betamethasone—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00262	0.0178	CrCrCtD
Betamethasone—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.00262	0.0178	CrCrCtD
Betamethasone—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.00257	0.0174	CrCrCtD
Betamethasone—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.00251	0.0171	CrCrCtD
Betamethasone—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.00251	0.017	CrCrCtD
Betamethasone—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00241	0.0164	CrCrCtD
Betamethasone—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00236	0.016	CrCrCtD
Betamethasone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00195	0.0202	CbGbCtD
Betamethasone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00184	0.0191	CbGbCtD
Betamethasone—PLA2G1B—respiratory system—chronic obstructive pulmonary disease	0.000636	0.103	CbGeAlD
Betamethasone—PTGS2—leg—chronic obstructive pulmonary disease	0.000588	0.095	CbGeAlD
Betamethasone—PLA2G1B—connective tissue—chronic obstructive pulmonary disease	0.000559	0.0903	CbGeAlD
Betamethasone—PLA2G1B—lung—chronic obstructive pulmonary disease	0.000337	0.0545	CbGeAlD
Betamethasone—PGR—respiratory system—chronic obstructive pulmonary disease	0.000293	0.0472	CbGeAlD
Betamethasone—NR3C2—connective tissue—chronic obstructive pulmonary disease	0.000277	0.0447	CbGeAlD
Betamethasone—NR3C2—bronchus—chronic obstructive pulmonary disease	0.000259	0.0418	CbGeAlD
Betamethasone—PGR—connective tissue—chronic obstructive pulmonary disease	0.000258	0.0416	CbGeAlD
Betamethasone—NR3C2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000253	0.0409	CbGeAlD
Betamethasone—PGR—smooth muscle tissue—chronic obstructive pulmonary disease	0.000236	0.038	CbGeAlD
Betamethasone—NR3C2—trachea—chronic obstructive pulmonary disease	0.000233	0.0376	CbGeAlD
Betamethasone—CYP19A1—connective tissue—chronic obstructive pulmonary disease	0.000232	0.0374	CbGeAlD
Betamethasone—NR3C1—respiratory system—chronic obstructive pulmonary disease	0.000169	0.0273	CbGeAlD
Betamethasone—NR3C2—lung—chronic obstructive pulmonary disease	0.000167	0.027	CbGeAlD
Betamethasone—PGR—lung—chronic obstructive pulmonary disease	0.000155	0.0251	CbGeAlD
Betamethasone—NR3C1—connective tissue—chronic obstructive pulmonary disease	0.000149	0.024	CbGeAlD
Betamethasone—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000146	0.0236	CbGeAlD
Betamethasone—NR3C1—bronchus—chronic obstructive pulmonary disease	0.000139	0.0224	CbGeAlD
Betamethasone—NR3C1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000136	0.022	CbGeAlD
Betamethasone—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000129	0.0208	CbGeAlD
Betamethasone—NR3C1—trachea—chronic obstructive pulmonary disease	0.000125	0.0201	CbGeAlD
Betamethasone—PTGS2—bronchus—chronic obstructive pulmonary disease	0.00012	0.0194	CbGeAlD
Betamethasone—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000118	0.019	CbGeAlD
Betamethasone—PTGS2—trachea—chronic obstructive pulmonary disease	0.000108	0.0174	CbGeAlD
Betamethasone—ABCB1—respiratory system—chronic obstructive pulmonary disease	9.04e-05	0.0146	CbGeAlD
Betamethasone—NR3C1—lung—chronic obstructive pulmonary disease	8.96e-05	0.0145	CbGeAlD
Betamethasone—PTGS2—lung—chronic obstructive pulmonary disease	7.76e-05	0.0125	CbGeAlD
Betamethasone—ABCB1—trachea—chronic obstructive pulmonary disease	6.68e-05	0.0108	CbGeAlD
Betamethasone—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	6.17e-05	0.282	CrCbGaD
Betamethasone—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	5.95e-05	0.272	CrCbGaD
Betamethasone—Dexamethasone—NOS2—chronic obstructive pulmonary disease	5.03e-05	0.23	CrCbGaD
Betamethasone—ABCB1—lung—chronic obstructive pulmonary disease	4.8e-05	0.00775	CbGeAlD
Betamethasone—Syncope—Salbutamol—chronic obstructive pulmonary disease	3.46e-05	0.000774	CcSEcCtD
Betamethasone—Neuropathy—Prednisone—chronic obstructive pulmonary disease	3.45e-05	0.000772	CcSEcCtD
Betamethasone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	3.43e-05	0.000769	CcSEcCtD
Betamethasone—Discomfort—Formoterol—chronic obstructive pulmonary disease	3.43e-05	0.000769	CcSEcCtD
Betamethasone—Myalgia—Montelukast—chronic obstructive pulmonary disease	3.4e-05	0.000762	CcSEcCtD
Betamethasone—Anxiety—Montelukast—chronic obstructive pulmonary disease	3.39e-05	0.000759	CcSEcCtD
Betamethasone—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	3.39e-05	0.000758	CcSEcCtD
Betamethasone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	3.38e-05	0.000756	CcSEcCtD
Betamethasone—Dry skin—Prednisolone—chronic obstructive pulmonary disease	3.37e-05	0.000753	CcSEcCtD
Betamethasone—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	3.36e-05	0.000752	CcSEcCtD
Betamethasone—Oedema—Formoterol—chronic obstructive pulmonary disease	3.33e-05	0.000746	CcSEcCtD
Betamethasone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	3.33e-05	0.000746	CcSEcCtD
Betamethasone—Oedema—Arformoterol—chronic obstructive pulmonary disease	3.33e-05	0.000746	CcSEcCtD
Betamethasone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	3.33e-05	0.000746	CcSEcCtD
Betamethasone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	3.33e-05	0.000745	CcSEcCtD
Betamethasone—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	3.32e-05	0.000744	CcSEcCtD
Betamethasone—Infection—Arformoterol—chronic obstructive pulmonary disease	3.31e-05	0.000741	CcSEcCtD
Betamethasone—Infection—Formoterol—chronic obstructive pulmonary disease	3.31e-05	0.000741	CcSEcCtD
Betamethasone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	3.28e-05	0.000734	CcSEcCtD
Betamethasone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	3.28e-05	0.000734	CcSEcCtD
Betamethasone—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	3.27e-05	0.000732	CcSEcCtD
Betamethasone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	3.27e-05	0.000732	CcSEcCtD
Betamethasone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	3.27e-05	0.000731	CcSEcCtD
Betamethasone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	3.27e-05	0.000731	CcSEcCtD
Betamethasone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	3.26e-05	0.00073	CcSEcCtD
Betamethasone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	3.26e-05	0.00073	CcSEcCtD
Betamethasone—Oedema—Montelukast—chronic obstructive pulmonary disease	3.26e-05	0.00073	CcSEcCtD
Betamethasone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	3.25e-05	0.000728	CcSEcCtD
Betamethasone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	3.25e-05	0.000728	CcSEcCtD
Betamethasone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	3.24e-05	0.000726	CcSEcCtD
Betamethasone—Infection—Montelukast—chronic obstructive pulmonary disease	3.24e-05	0.000726	CcSEcCtD
Betamethasone—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	3.24e-05	0.000725	CcSEcCtD
Betamethasone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	3.2e-05	0.000716	CcSEcCtD
Betamethasone—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	3.2e-05	0.000715	CcSEcCtD
Betamethasone—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	3.16e-05	0.000707	CcSEcCtD
Betamethasone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	3.15e-05	0.000704	CcSEcCtD
Betamethasone—Oedema—Salbutamol—chronic obstructive pulmonary disease	3.15e-05	0.000704	CcSEcCtD
Betamethasone—Infection—Salbutamol—chronic obstructive pulmonary disease	3.13e-05	0.000699	CcSEcCtD
Betamethasone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	3.11e-05	0.000697	CcSEcCtD
Betamethasone—Hypotension—Formoterol—chronic obstructive pulmonary disease	3.11e-05	0.000697	CcSEcCtD
Betamethasone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	3.1e-05	0.000693	CcSEcCtD
Betamethasone—Shock—Salbutamol—chronic obstructive pulmonary disease	3.1e-05	0.000693	CcSEcCtD
Betamethasone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	3.09e-05	0.000692	CcSEcCtD
Betamethasone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	3.09e-05	0.00069	CcSEcCtD
Betamethasone—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	3.08e-05	0.00069	CcSEcCtD
Betamethasone—CYP19A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.08e-05	0.00421	CbGpPWpGaD
Betamethasone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	3.07e-05	0.000687	CcSEcCtD
Betamethasone—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	3.07e-05	0.000686	CcSEcCtD
Betamethasone—CYP19A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.04e-05	0.00416	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	3.04e-05	0.000681	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	3.04e-05	0.000679	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	3.04e-05	0.000679	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	3.04e-05	0.00415	CbGpPWpGaD
Betamethasone—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	3.03e-05	0.00414	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	3.02e-05	0.00412	CbGpPWpGaD
Betamethasone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	3.01e-05	0.000674	CcSEcCtD
Betamethasone—Insomnia—Formoterol—chronic obstructive pulmonary disease	3.01e-05	0.000674	CcSEcCtD
Betamethasone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	3e-05	0.000671	CcSEcCtD
Betamethasone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	3e-05	0.00067	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	2.99e-05	0.00408	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	2.97e-05	0.000665	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	2.96e-05	0.00405	CbGpPWpGaD
Betamethasone—Insomnia—Montelukast—chronic obstructive pulmonary disease	2.95e-05	0.000661	CcSEcCtD
Betamethasone—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	2.94e-05	0.000658	CcSEcCtD
Betamethasone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	2.94e-05	0.000658	CcSEcCtD
Betamethasone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	2.93e-05	0.000656	CcSEcCtD
Betamethasone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	2.93e-05	0.000656	CcSEcCtD
Betamethasone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	2.93e-05	0.000656	CcSEcCtD
Betamethasone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	2.92e-05	0.000654	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.92e-05	0.00399	CbGpPWpGaD
Betamethasone—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	2.92e-05	0.00399	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	2.91e-05	0.00397	CbGpPWpGaD
Betamethasone—Injury—Prednisone—chronic obstructive pulmonary disease	2.9e-05	0.00065	CcSEcCtD
Betamethasone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	2.9e-05	0.000648	CcSEcCtD
Betamethasone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	2.89e-05	0.000646	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	2.88e-05	0.000644	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	2.88e-05	0.000644	CcSEcCtD
Betamethasone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	2.87e-05	0.000643	CcSEcCtD
Betamethasone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	2.87e-05	0.000643	CcSEcCtD
Betamethasone—Fatigue—Formoterol—chronic obstructive pulmonary disease	2.87e-05	0.000643	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	2.87e-05	0.000641	CcSEcCtD
Betamethasone—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	2.86e-05	0.00391	CbGpPWpGaD
Betamethasone—Pain—Arformoterol—chronic obstructive pulmonary disease	2.85e-05	0.000638	CcSEcCtD
Betamethasone—Pain—Formoterol—chronic obstructive pulmonary disease	2.85e-05	0.000638	CcSEcCtD
Betamethasone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	2.85e-05	0.000637	CcSEcCtD
Betamethasone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	2.84e-05	0.000636	CcSEcCtD
Betamethasone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	2.83e-05	0.000632	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	2.82e-05	0.000631	CcSEcCtD
Betamethasone—Fatigue—Montelukast—chronic obstructive pulmonary disease	2.81e-05	0.00063	CcSEcCtD
Betamethasone—Pain—Montelukast—chronic obstructive pulmonary disease	2.79e-05	0.000625	CcSEcCtD
Betamethasone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	2.79e-05	0.000624	CcSEcCtD
Betamethasone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	2.78e-05	0.000623	CcSEcCtD
Betamethasone—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	2.78e-05	0.0038	CbGpPWpGaD
Betamethasone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	2.77e-05	0.000621	CcSEcCtD
Betamethasone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	2.77e-05	0.000621	CcSEcCtD
Betamethasone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	2.77e-05	0.00062	CcSEcCtD
Betamethasone—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	2.77e-05	0.00378	CbGpPWpGaD
Betamethasone—Rash—Aminophylline—chronic obstructive pulmonary disease	2.76e-05	0.000618	CcSEcCtD
Betamethasone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	2.76e-05	0.000617	CcSEcCtD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	2.75e-05	0.00376	CbGpPWpGaD
Betamethasone—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	2.75e-05	0.000615	CcSEcCtD
Betamethasone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	2.75e-05	0.000614	CcSEcCtD
Betamethasone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	2.75e-05	0.000614	CcSEcCtD
Betamethasone—Headache—Aminophylline—chronic obstructive pulmonary disease	2.74e-05	0.000614	CcSEcCtD
Betamethasone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	2.74e-05	0.000612	CcSEcCtD
Betamethasone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	2.73e-05	0.000612	CcSEcCtD
Betamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	2.73e-05	0.00373	CbGpPWpGaD
Betamethasone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	2.73e-05	0.000611	CcSEcCtD
Betamethasone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	2.72e-05	0.00061	CcSEcCtD
Betamethasone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	2.72e-05	0.00061	CcSEcCtD
Betamethasone—Lethargy—Prednisone—chronic obstructive pulmonary disease	2.72e-05	0.000609	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	2.72e-05	0.000608	CcSEcCtD
Betamethasone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	2.71e-05	0.000607	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.71e-05	0.00371	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	2.7e-05	0.00368	CbGpPWpGaD
Betamethasone—Pain—Salbutamol—chronic obstructive pulmonary disease	2.69e-05	0.000602	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.69e-05	0.00368	CbGpPWpGaD
Betamethasone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	2.67e-05	0.000597	CcSEcCtD
Betamethasone—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	2.67e-05	0.000597	CcSEcCtD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	2.66e-05	0.00363	CbGpPWpGaD
Betamethasone—Urticaria—Formoterol—chronic obstructive pulmonary disease	2.65e-05	0.000592	CcSEcCtD
Betamethasone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	2.65e-05	0.000592	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—GC—chronic obstructive pulmonary disease	2.64e-05	0.00361	CbGpPWpGaD
Betamethasone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	2.63e-05	0.000589	CcSEcCtD
Betamethasone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	2.63e-05	0.000589	CcSEcCtD
Betamethasone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	2.63e-05	0.000589	CcSEcCtD
Betamethasone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	2.63e-05	0.000589	CcSEcCtD
Betamethasone—Affect lability—Prednisone—chronic obstructive pulmonary disease	2.63e-05	0.000588	CcSEcCtD
Betamethasone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	2.63e-05	0.000587	CcSEcCtD
Betamethasone—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	2.61e-05	0.000583	CcSEcCtD
Betamethasone—Rash—Tiotropium—chronic obstructive pulmonary disease	2.6e-05	0.000583	CcSEcCtD
Betamethasone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	2.6e-05	0.000582	CcSEcCtD
Betamethasone—Nausea—Aminophylline—chronic obstructive pulmonary disease	2.6e-05	0.000582	CcSEcCtD
Betamethasone—Urticaria—Montelukast—chronic obstructive pulmonary disease	2.59e-05	0.00058	CcSEcCtD
Betamethasone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	2.59e-05	0.00058	CcSEcCtD
Betamethasone—Headache—Tiotropium—chronic obstructive pulmonary disease	2.59e-05	0.000579	CcSEcCtD
Betamethasone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	2.59e-05	0.000579	CcSEcCtD
Betamethasone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	2.58e-05	0.000577	CcSEcCtD
Betamethasone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	2.58e-05	0.000577	CcSEcCtD
Betamethasone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	2.57e-05	0.000576	CcSEcCtD
Betamethasone—CYP19A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.56e-05	0.0035	CbGpPWpGaD
Betamethasone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	2.55e-05	0.000571	CcSEcCtD
Betamethasone—Irritability—Prednisone—chronic obstructive pulmonary disease	2.55e-05	0.00057	CcSEcCtD
Betamethasone—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	2.55e-05	0.00348	CbGpPWpGaD
Betamethasone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	2.54e-05	0.000568	CcSEcCtD
Betamethasone—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	2.54e-05	0.000568	CcSEcCtD
Betamethasone—Mood swings—Prednisone—chronic obstructive pulmonary disease	2.53e-05	0.000566	CcSEcCtD
Betamethasone—CYP19A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.52e-05	0.00345	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	2.52e-05	0.00345	CbGpPWpGaD
Betamethasone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	2.5e-05	0.000559	CcSEcCtD
Betamethasone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	2.49e-05	0.000557	CcSEcCtD
Betamethasone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	2.49e-05	0.000557	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.45e-05	0.00335	CbGpPWpGaD
Betamethasone—Nausea—Tiotropium—chronic obstructive pulmonary disease	2.45e-05	0.000549	CcSEcCtD
Betamethasone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	2.45e-05	0.000548	CcSEcCtD
Betamethasone—Prednisone—ALB—chronic obstructive pulmonary disease	2.45e-05	0.112	CrCbGaD
Betamethasone—Dry skin—Prednisone—chronic obstructive pulmonary disease	2.45e-05	0.000547	CcSEcCtD
Betamethasone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	2.43e-05	0.000543	CcSEcCtD
Betamethasone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	2.39e-05	0.000535	CcSEcCtD
Betamethasone—Asthenia—Formoterol—chronic obstructive pulmonary disease	2.39e-05	0.000535	CcSEcCtD
Betamethasone—Pruritus—Formoterol—chronic obstructive pulmonary disease	2.36e-05	0.000528	CcSEcCtD
Betamethasone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	2.36e-05	0.000528	CcSEcCtD
Betamethasone—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	2.35e-05	0.000527	CcSEcCtD
Betamethasone—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	2.34e-05	0.0032	CbGpPWpGaD
Betamethasone—Asthenia—Montelukast—chronic obstructive pulmonary disease	2.34e-05	0.000524	CcSEcCtD
Betamethasone—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	2.32e-05	0.00318	CbGpPWpGaD
Betamethasone—Pruritus—Montelukast—chronic obstructive pulmonary disease	2.31e-05	0.000517	CcSEcCtD
Betamethasone—Dexamethasone—CYP1A1—chronic obstructive pulmonary disease	2.31e-05	0.105	CrCbGaD
Betamethasone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	2.28e-05	0.00051	CcSEcCtD
Betamethasone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	2.28e-05	0.00051	CcSEcCtD
Betamethasone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	2.27e-05	0.000508	CcSEcCtD
Betamethasone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	2.26e-05	0.000505	CcSEcCtD
Betamethasone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	2.25e-05	0.000503	CcSEcCtD
Betamethasone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	2.23e-05	0.0005	CcSEcCtD
Betamethasone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	2.23e-05	0.000498	CcSEcCtD
Betamethasone—Erythema—Prednisolone—chronic obstructive pulmonary disease	2.21e-05	0.000495	CcSEcCtD
Betamethasone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	2.2e-05	0.000493	CcSEcCtD
Betamethasone—Dizziness—Formoterol—chronic obstructive pulmonary disease	2.2e-05	0.000493	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.16e-05	0.00296	CbGpPWpGaD
Betamethasone—Dizziness—Montelukast—chronic obstructive pulmonary disease	2.16e-05	0.000483	CcSEcCtD
Betamethasone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	2.15e-05	0.000482	CcSEcCtD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	2.14e-05	0.00293	CbGpPWpGaD
Betamethasone—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	2.14e-05	0.00293	CbGpPWpGaD
Betamethasone—CYP19A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.13e-05	0.00292	CbGpPWpGaD
Betamethasone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	2.12e-05	0.000474	CcSEcCtD
Betamethasone—Vomiting—Formoterol—chronic obstructive pulmonary disease	2.12e-05	0.000474	CcSEcCtD
Betamethasone—CYP19A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.1e-05	0.00287	CbGpPWpGaD
Betamethasone—Rash—Formoterol—chronic obstructive pulmonary disease	2.1e-05	0.00047	CcSEcCtD
Betamethasone—Rash—Arformoterol—chronic obstructive pulmonary disease	2.1e-05	0.00047	CcSEcCtD
Betamethasone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	2.1e-05	0.00047	CcSEcCtD
Betamethasone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	2.1e-05	0.00047	CcSEcCtD
Betamethasone—Weight increased—Prednisone—chronic obstructive pulmonary disease	2.1e-05	0.00047	CcSEcCtD
Betamethasone—Headache—Arformoterol—chronic obstructive pulmonary disease	2.09e-05	0.000467	CcSEcCtD
Betamethasone—Headache—Formoterol—chronic obstructive pulmonary disease	2.09e-05	0.000467	CcSEcCtD
Betamethasone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	2.09e-05	0.000467	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.09e-05	0.00285	CbGpPWpGaD
Betamethasone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	2.08e-05	0.000466	CcSEcCtD
Betamethasone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	2.08e-05	0.000466	CcSEcCtD
Betamethasone—Vomiting—Montelukast—chronic obstructive pulmonary disease	2.08e-05	0.000464	CcSEcCtD
Betamethasone—Rash—Montelukast—chronic obstructive pulmonary disease	2.06e-05	0.000461	CcSEcCtD
Betamethasone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	2.06e-05	0.00046	CcSEcCtD
Betamethasone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	2.05e-05	0.000459	CcSEcCtD
Betamethasone—Headache—Montelukast—chronic obstructive pulmonary disease	2.04e-05	0.000458	CcSEcCtD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	2.04e-05	0.00279	CbGpPWpGaD
Betamethasone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	2.03e-05	0.000454	CcSEcCtD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	2.02e-05	0.00276	CbGpPWpGaD
Betamethasone—Angioedema—Prednisolone—chronic obstructive pulmonary disease	2.02e-05	0.000452	CcSEcCtD
Betamethasone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	2.02e-05	0.000451	CcSEcCtD
Betamethasone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	2.02e-05	0.000451	CcSEcCtD
Betamethasone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	2e-05	0.000448	CcSEcCtD
Betamethasone—Malaise—Prednisolone—chronic obstructive pulmonary disease	1.99e-05	0.000446	CcSEcCtD
Betamethasone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	1.99e-05	0.000445	CcSEcCtD
Betamethasone—Rash—Salbutamol—chronic obstructive pulmonary disease	1.98e-05	0.000444	CcSEcCtD
Betamethasone—Syncope—Prednisolone—chronic obstructive pulmonary disease	1.98e-05	0.000444	CcSEcCtD
Betamethasone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	1.98e-05	0.000444	CcSEcCtD
Betamethasone—Nausea—Arformoterol—chronic obstructive pulmonary disease	1.98e-05	0.000443	CcSEcCtD
Betamethasone—Nausea—Formoterol—chronic obstructive pulmonary disease	1.98e-05	0.000443	CcSEcCtD
Betamethasone—Headache—Salbutamol—chronic obstructive pulmonary disease	1.97e-05	0.000441	CcSEcCtD
Betamethasone—CYP19A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.96e-05	0.00268	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.95e-05	0.00267	CbGpPWpGaD
Betamethasone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	1.94e-05	0.000435	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	1.94e-05	0.00265	CbGpPWpGaD
Betamethasone—Nausea—Montelukast—chronic obstructive pulmonary disease	1.94e-05	0.000434	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	1.93e-05	0.00264	CbGpPWpGaD
Betamethasone—CYP19A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.93e-05	0.00264	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	1.92e-05	0.00263	CbGpPWpGaD
Betamethasone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	1.92e-05	0.000429	CcSEcCtD
Betamethasone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	1.91e-05	0.000427	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	1.88e-05	0.00257	CbGpPWpGaD
Betamethasone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	1.88e-05	0.00042	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	1.87e-05	0.00255	CbGpPWpGaD
Betamethasone—Nausea—Salbutamol—chronic obstructive pulmonary disease	1.87e-05	0.000418	CcSEcCtD
Betamethasone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	1.86e-05	0.000416	CcSEcCtD
Betamethasone—CYP19A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.86e-05	0.00254	CbGpPWpGaD
Betamethasone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	1.86e-05	0.000415	CcSEcCtD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	1.85e-05	0.00253	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	1.85e-05	0.00253	CbGpPWpGaD
Betamethasone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	1.85e-05	0.000413	CcSEcCtD
Betamethasone—Hallucination—Prednisone—chronic obstructive pulmonary disease	1.84e-05	0.000411	CcSEcCtD
Betamethasone—CYP19A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.83e-05	0.0025	CbGpPWpGaD
Betamethasone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	1.8e-05	0.000404	CcSEcCtD
Betamethasone—Oedema—Prednisolone—chronic obstructive pulmonary disease	1.8e-05	0.000404	CcSEcCtD
Betamethasone—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	1.78e-05	0.00243	CbGpPWpGaD
Betamethasone—Shock—Prednisolone—chronic obstructive pulmonary disease	1.78e-05	0.000397	CcSEcCtD
Betamethasone—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	1.77e-05	0.00242	CbGpPWpGaD
Betamethasone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	1.76e-05	0.000394	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	1.75e-05	0.0024	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	1.74e-05	0.00039	CcSEcCtD
Betamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	1.73e-05	0.00237	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	1.73e-05	0.00236	CbGpPWpGaD
Betamethasone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	1.72e-05	0.000386	CcSEcCtD
Betamethasone—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	1.71e-05	0.00234	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	1.71e-05	0.00234	CbGpPWpGaD
Betamethasone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	1.67e-05	0.000375	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	1.67e-05	0.00228	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	1.65e-05	0.00226	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	1.65e-05	0.00226	CbGpPWpGaD
Betamethasone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	1.65e-05	0.000369	CcSEcCtD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	1.64e-05	0.00225	CbGpPWpGaD
Betamethasone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	1.63e-05	0.000365	CcSEcCtD
Betamethasone—Alopecia—Prednisone—chronic obstructive pulmonary disease	1.63e-05	0.000365	CcSEcCtD
Betamethasone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	1.62e-05	0.000363	CcSEcCtD
Betamethasone—Erythema—Prednisone—chronic obstructive pulmonary disease	1.61e-05	0.00036	CcSEcCtD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	1.57e-05	0.00215	CbGpPWpGaD
Betamethasone—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	1.56e-05	0.00213	CbGpPWpGaD
Betamethasone—Pain—Prednisolone—chronic obstructive pulmonary disease	1.54e-05	0.000345	CcSEcCtD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	1.53e-05	0.00209	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—CTGF—chronic obstructive pulmonary disease	1.53e-05	0.00209	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	1.5e-05	0.00205	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	1.5e-05	0.00204	CbGpPWpGaD
Betamethasone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	1.49e-05	0.000334	CcSEcCtD
Betamethasone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	1.49e-05	0.000333	CcSEcCtD
Betamethasone—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	1.48e-05	0.00202	CbGpPWpGaD
Betamethasone—Angioedema—Prednisone—chronic obstructive pulmonary disease	1.47e-05	0.000329	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	1.46e-05	0.00199	CbGpPWpGaD
Betamethasone—Malaise—Prednisone—chronic obstructive pulmonary disease	1.45e-05	0.000324	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	1.45e-05	0.00198	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	1.45e-05	0.00198	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	1.45e-05	0.00198	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.45e-05	0.00198	CbGpPWpGaD
Betamethasone—Vertigo—Prednisone—chronic obstructive pulmonary disease	1.44e-05	0.000323	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	1.44e-05	0.00197	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.44e-05	0.00197	CbGpPWpGaD
Betamethasone—Syncope—Prednisone—chronic obstructive pulmonary disease	1.44e-05	0.000322	CcSEcCtD
Betamethasone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	1.43e-05	0.000321	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	1.43e-05	0.00196	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	1.43e-05	0.00195	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.42e-05	0.00195	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GCLC—chronic obstructive pulmonary disease	1.42e-05	0.00195	CbGpPWpGaD
Betamethasone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	1.41e-05	0.000316	CcSEcCtD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	1.41e-05	0.00192	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	1.4e-05	0.00191	CbGpPWpGaD
Betamethasone—Convulsion—Prednisone—chronic obstructive pulmonary disease	1.39e-05	0.000312	CcSEcCtD
Betamethasone—Hypertension—Prednisone—chronic obstructive pulmonary disease	1.39e-05	0.00031	CcSEcCtD
Betamethasone—Myalgia—Prednisone—chronic obstructive pulmonary disease	1.37e-05	0.000306	CcSEcCtD
Betamethasone—Anxiety—Prednisone—chronic obstructive pulmonary disease	1.36e-05	0.000305	CcSEcCtD
Betamethasone—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	1.36e-05	0.00186	CbGpPWpGaD
Betamethasone—Discomfort—Prednisone—chronic obstructive pulmonary disease	1.35e-05	0.000302	CcSEcCtD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	1.34e-05	0.00183	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.33e-05	0.00182	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	1.32e-05	0.0018	CbGpPWpGaD
Betamethasone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	1.31e-05	0.000293	CcSEcCtD
Betamethasone—Oedema—Prednisone—chronic obstructive pulmonary disease	1.31e-05	0.000293	CcSEcCtD
Betamethasone—Infection—Prednisone—chronic obstructive pulmonary disease	1.3e-05	0.000292	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—CTGF—chronic obstructive pulmonary disease	1.3e-05	0.00178	CbGpPWpGaD
Betamethasone—Shock—Prednisone—chronic obstructive pulmonary disease	1.29e-05	0.000289	CcSEcCtD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	1.29e-05	0.00176	CbGpPWpGaD
Betamethasone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	1.29e-05	0.000288	CcSEcCtD
Betamethasone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	1.28e-05	0.000286	CcSEcCtD
Betamethasone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	1.27e-05	0.000284	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.26e-05	0.00173	CbGpPWpGaD
Betamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	1.26e-05	0.00172	CbGpPWpGaD
Betamethasone—Anorexia—Prednisone—chronic obstructive pulmonary disease	1.25e-05	0.00028	CcSEcCtD
Betamethasone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.0017	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.2e-05	0.00164	CbGpPWpGaD
Betamethasone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	1.19e-05	0.000267	CcSEcCtD
Betamethasone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	1.19e-05	0.000267	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	1.19e-05	0.00163	CbGpPWpGaD
Betamethasone—Insomnia—Prednisone—chronic obstructive pulmonary disease	1.19e-05	0.000265	CcSEcCtD
Betamethasone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	1.18e-05	0.000264	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	1.17e-05	0.0016	CbGpPWpGaD
Betamethasone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	1.15e-05	0.000258	CcSEcCtD
Betamethasone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	1.14e-05	0.000255	CcSEcCtD
Betamethasone—Rash—Prednisolone—chronic obstructive pulmonary disease	1.14e-05	0.000255	CcSEcCtD
Betamethasone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	1.14e-05	0.000254	CcSEcCtD
Betamethasone—Fatigue—Prednisone—chronic obstructive pulmonary disease	1.13e-05	0.000253	CcSEcCtD
Betamethasone—Headache—Prednisolone—chronic obstructive pulmonary disease	1.13e-05	0.000253	CcSEcCtD
Betamethasone—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	1.12e-05	0.00153	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	1.09e-05	0.00149	CbGpPWpGaD
Betamethasone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	1.08e-05	0.000242	CcSEcCtD
Betamethasone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	1.07e-05	0.00024	CcSEcCtD
Betamethasone—Nausea—Prednisolone—chronic obstructive pulmonary disease	1.07e-05	0.00024	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.07e-05	0.00146	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	1.05e-05	0.00143	CbGpPWpGaD
Betamethasone—Urticaria—Prednisone—chronic obstructive pulmonary disease	1.04e-05	0.000233	CcSEcCtD
Betamethasone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	1.04e-05	0.000232	CcSEcCtD
Betamethasone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	1.04e-05	0.000232	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	1.02e-05	0.0014	CbGpPWpGaD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.0014	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	1.01e-05	0.00139	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	9.99e-06	0.00137	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.99e-06	0.00137	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.9e-06	0.00135	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.85e-06	0.00135	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.82e-06	0.00134	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	9.8e-06	0.00134	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	9.68e-06	0.00132	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	9.66e-06	0.00132	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	9.64e-06	0.00132	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	9.6e-06	0.00131	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.57e-06	0.00131	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	9.46e-06	0.00129	CbGpPWpGaD
Betamethasone—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.41e-06	0.000211	CcSEcCtD
Betamethasone—PGR—Gene Expression—CTGF—chronic obstructive pulmonary disease	9.31e-06	0.00127	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	9.29e-06	0.00127	CbGpPWpGaD
Betamethasone—Pruritus—Prednisone—chronic obstructive pulmonary disease	9.28e-06	0.000208	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.18e-06	0.00125	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	9.08e-06	0.00124	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.98e-06	0.00123	CbGpPWpGaD
Betamethasone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.97e-06	0.000201	CcSEcCtD
Betamethasone—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.96e-06	0.00122	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.88e-06	0.00121	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	8.87e-06	0.00121	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	8.82e-06	0.00121	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	8.81e-06	0.0012	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	8.76e-06	0.0012	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.7e-06	0.00119	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	8.7e-06	0.00119	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	8.68e-06	0.00119	CbGpPWpGaD
Betamethasone—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.67e-06	0.000194	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	8.52e-06	0.00116	CbGpPWpGaD
Betamethasone—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.34e-06	0.000187	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	8.3e-06	0.00113	CbGpPWpGaD
Betamethasone—Rash—Prednisone—chronic obstructive pulmonary disease	8.27e-06	0.000185	CcSEcCtD
Betamethasone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.26e-06	0.000185	CcSEcCtD
Betamethasone—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	8.23e-06	0.00112	CbGpPWpGaD
Betamethasone—Headache—Prednisone—chronic obstructive pulmonary disease	8.21e-06	0.000184	CcSEcCtD
Betamethasone—Nausea—Prednisone—chronic obstructive pulmonary disease	7.79e-06	0.000174	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	7.72e-06	0.00105	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	7.68e-06	0.00105	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.46e-06	0.00102	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.36e-06	0.00101	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	7.3e-06	0.000998	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	7.22e-06	0.000986	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.14e-06	0.000975	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.12e-06	0.000973	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.11e-06	0.000972	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	7.08e-06	0.000968	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	7.08e-06	0.000967	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	7.05e-06	0.000964	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	6.97e-06	0.000953	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	6.88e-06	0.00094	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	6.74e-06	0.000921	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	6.64e-06	0.000908	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.62e-06	0.000904	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	6.59e-06	0.0009	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.56e-06	0.000897	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	6.44e-06	0.00088	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.23e-06	0.000851	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.14e-06	0.000839	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.99e-06	0.000818	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	5.94e-06	0.000812	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—ALB—chronic obstructive pulmonary disease	5.92e-06	0.000808	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.74e-06	0.000784	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.72e-06	0.000782	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—NOS3—chronic obstructive pulmonary disease	5.66e-06	0.000773	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.64e-06	0.000771	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.64e-06	0.000771	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	5.44e-06	0.000743	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.42e-06	0.000741	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	5.38e-06	0.000736	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.35e-06	0.000731	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.35e-06	0.000731	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.26e-06	0.000719	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.25e-06	0.000717	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.2e-06	0.000711	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	5.1e-06	0.000697	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	5.02e-06	0.000685	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.91e-06	0.000671	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.85e-06	0.000663	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.84e-06	0.000661	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.81e-06	0.000658	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.77e-06	0.000652	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.75e-06	0.000649	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.69e-06	0.000641	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.58e-06	0.000626	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	4.56e-06	0.000624	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.37e-06	0.000598	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	4.36e-06	0.000596	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.33e-06	0.000591	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	4.25e-06	0.00058	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.24e-06	0.00058	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	4.04e-06	0.000552	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.93e-06	0.000537	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.79e-06	0.000518	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.78e-06	0.000517	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.65e-06	0.000499	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.64e-06	0.000497	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.6e-06	0.000492	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	3.53e-06	0.000482	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.52e-06	0.000481	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.52e-06	0.000481	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.48e-06	0.000476	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	3.48e-06	0.000475	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.41e-06	0.000466	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.35e-06	0.000458	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KL—chronic obstructive pulmonary disease	3.28e-06	0.000448	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.25e-06	0.000444	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.24e-06	0.000443	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.18e-06	0.000434	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	3.17e-06	0.000433	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.92e-06	0.000399	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.89e-06	0.000395	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.87e-06	0.000392	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.81e-06	0.000384	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.76e-06	0.000377	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.64e-06	0.00036	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.61e-06	0.000357	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.49e-06	0.000341	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.46e-06	0.000337	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	2.46e-06	0.000336	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.45e-06	0.000335	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.44e-06	0.000333	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.4e-06	0.000329	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.34e-06	0.000319	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.25e-06	0.000307	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.24e-06	0.000306	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.18e-06	0.000299	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.16e-06	0.000295	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.12e-06	0.00029	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.11e-06	0.000289	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.07e-06	0.000283	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.07e-06	0.000282	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	2.05e-06	0.00028	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.9e-06	0.000259	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.74e-06	0.000238	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.73e-06	0.000236	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	1.73e-06	0.000236	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.71e-06	0.000234	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.7e-06	0.000233	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	1.65e-06	0.000225	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.59e-06	0.000217	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.54e-06	0.00021	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.52e-06	0.000207	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.51e-06	0.000206	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	1.44e-06	0.000197	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.43e-06	0.000196	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.39e-06	0.000189	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.38e-06	0.000189	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.31e-06	0.000179	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.28e-06	0.000174	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	1.09e-06	0.000149	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	1.07e-06	0.000146	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.06e-06	0.000145	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.05e-06	0.000143	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.02e-06	0.00014	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.79e-07	0.000134	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.78e-07	0.000134	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.28e-07	0.000127	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	8.22e-07	0.000112	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	6.31e-07	8.61e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	6.03e-07	8.24e-05	CbGpPWpGaD
